diaMentis reaches an important milestone in optimizing and accelerating the diagnosis of mental illnesses

QUEBEC, Feb. 5, 2025 /PRNewswire/ - Holder of an innovative diagnostic support technology, recognized by the Food and Drug Administration (FDA) as a major scientific breakthrough, diaMentis unveils unprecedented results for the optimization and acceleration of mental illness diagnosis,...